Jason Breen

On June 23, 2026, Merck KGaA, Darmstadt, Germany, a leading global science and technology company, announced a strategic collaboration with Versant Ventures to launch Saturnus Bio, a next-generation precision cardiology company that utilizes targeted gene modulation to address rare mono-genetic cardiomyopathies with significant unmet need. Wilson Sonsini Goodrich & Rosati advised Saturnus Bio on the transaction.

View Agenda Wilson Sonsini’s 2nd Annual Biotech Summit will address topics of critical importance to biotech and biopharmaceutical companies, including early and late-stage venture financing, partnering strategies, current and future AI trends in healthcare, and developments in M&A.

May 8, 2025 June 5th - 6th San Francisco, CA Brian Appel, Christine Au-Yeung, Jason Breen, Matthew Bresnahan, Barath Chari, Brendan Coffman, Ellie Han, Eric Hsu, James Huie, Michael Klippert, Andrea Linna, Hale Melnick, Danielle Naftulin, Philip Oettinger, Elton Satusky, Eva Yin Wilson Sonsini Goodrich & Rosati + Follow x Following x Following - Unfollow Contact To embed, copy and paste the code into your website or blog: June 5th - 6th, 2025 1:00 PM - 6:30 PM PDT InterContinental 888 Howard...